(+035) 527-1710-70
GLUCORA, SUPPORT HEALTHY GLUCOSE METABOLISM, NPN
SALT LAKE CITY and TORONTO, January 23, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical compan...
09
Mar
Press Releases
09
Mar
EASTGATE BIOTECH PROVIDES UPDATE ON ITS PATENT PORTFOLIO
EastGate Biotech Patent Portfolio Update:
SALT LAKE CITY and TORONTO, February 3, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB:...
09
Mar
EASTGATE BIOTECH ENGAGES DISTRIBUTION COMPANY FOR ITS NUTRACEUTICAL PRODUCTS FOR CANADIAN MARKET
SALT LAKE CITY and TORONTO, February 23, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: EBTI), an emerging pharmaceutical comp...
09
Mar
EASTGATE BIOTECH RECEIVES PURCHASE ORDER FROM ITS CANADIAN DISTRIBUTOR FOR NUTRACEUTICAL PRODUCTS
SALT LAKE CITY and TORONTO, March 11, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company ...
09
Mar
EASTGATE BIOTECH ANNOUNCES THAT PHARMACENTER LTD. WILL COMMENCE MARKETING THE COMPANY’S NUTRACEUTICAL PRODUCTS
SALT LAKE CITY and TORONTO, May 26, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company a...
09
Mar
EASTGATE BIOTECH ANNOUNCES COLLABORATION WITH THE UNIVERSITY OF GUELPH, DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY, FOR ITS NATURAL ANTIBACTERIAL PRODUCTS
SALT LAKE CITY and TORONTO, May 28, 2015 (Marketwire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company a...
09
Mar
UNIVERSITY OF GUELPH AND EASTGATE BIOTECH
EASTGATE BIOTECH ANNOUNCES THAT ITS RESEARCH COLLABORATOR, THE UNIVERSITY OF GUELPH, DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY R...
09
Dec
NEW STOCK SYMBOL ETBI
EASTGATE ACQUISITIONS ANNOUNCES NAME CHANGE TO EASTGATE BIOTECH CORP. AND NEW STOCK SYMBOL
SALT LAKE CITY and TORONTO, December 15, ...
09
Mar
EASTGATE ACQUISITIONS ANNOUNCES COMPLETION OF PRIVATE EQUITY INVESTMENT FINANCING
SALT LAKE CITY and TORONTO, Mar. 10, 2014 /PRNewswire/ — EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceuti...
09
Mar
EASTGATE ACQUISITIONS PRESENTS AN INTRODUCTION TO ITS SELF-EMULSIFYING PLATFORM DELIVERY SYSTEM FOR ENHANCING BIOAVAILABILITY OF BIOLOGICALLY ACTIVE COMPOUNDS
SALT LAKE CITY and TORONTO, May 20, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical...